Lancer Orthodontics Inc(LANZ)
USD --+0.00%
Reward44Moderate
Risk41Moderate
📊75%Data
Thin 2% profit margin · Revenue growing 12% YoY
LANZ
+0.0 · +0.00%
USD · PINK
Lancer Orthodontics Inc | Healthcare
Capital Destroyer
Market Cap:28.91M
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
41
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on LANZ to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Lancer Orthodontics Inc?

designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide.

LANZ · Verdict

Moderate reward · moderate risk

LANZ stands out on volatility and balance sheet, but watch the profitability signal.

Based on 88% data coverage

LANZ · Verdict

What’s working & what to watch

Strengths 2

  • Volatility80/100

    Top decile vs peers

  • Balance sheet76/100

    Current ratio 5.41

Watchouts 2

  • Profitability10/100

    0% net margin · 3% ROE

  • Cash flow34/100

    -8% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Lancer Orthodontics Inc?

designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide. It offers aesthetic brackets, brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and miscellaneous products. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 28.91M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap28.91M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.027
52 Week Low0.0015
Last AnnualMay
IPO Date1/1/1987
IncorporatedUSA
Shares OutstandingN/A
No. of Employees134
IndustryMedical Instruments & Supplies
ExchangePINK
Beta0.5
CurrencyUSD